Thursday, March 16, 2017 4:04:39 PM
There was no growth in the second half, compared to last year, plain and simple fact.
If any one is playing with the numbers it's JN not me. Remember the supposedly 3rd quarter sales carry over, that don't appear in the 4th quarter, because if they did the fourth quarter numbers would have been horrible.
The numbers are what they are.
Even more disturbing they did 51.4 million in the first half and only 36.1 the second half of the year.
A 15.3 million decrease from first half to second half, with supposedly a 42 million in backlog.
There a problem somewhere.
What is your opinion?
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM